Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • HM43239 for AML
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • HM43239 for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia

Jun 02, 2015 2:00pm EDT

Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015

May 05, 2015 4:15pm EDT

Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board

Mar 23, 2015 8:30am EDT

Aptose Biosciences to Present at the 12th Annual BIO Asia International Conference

Mar 23, 2015 8:00am EDT

Aptose Biosciences to Present at the 27th Annual ROTH Conference

Mar 05, 2015 8:00am EST

Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014

Mar 03, 2015 4:30pm EST

Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and Webcast

Feb 26, 2015 8:00am EST

Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare Conference

Feb 25, 2015 4:39pm EST

Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare Conference

Feb 19, 2015 8:00am EST

Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee

Jan 20, 2015 5:02pm EST
RSS
  • Prev
    • 1...
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    Next
    © 2022 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap